Skip to content

Author

Yu-Ping Deng

We have 1 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Anti‐PD‐1/CTLA‐4 bispecific antibody‐based combination therapy for cervical cancer: a multicenter study with biomarker analysis

Background Cadonilimab is a PD‐1/CTLA‐4 bispecific antibody with robust activity in platinum‐pretreated advanced cervical cancer, while its first‐line value and resistance mechanisms remain unclear. Methods This multicenter retrospective study enrolled 52 treatment‐naive patients with recurrent/metastatic cervical canc...

Ji-Wei Li, Yu-Ping Deng, Tao Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.